홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Iodide → (6R,7R)-3-[[5-amino-4-[[(2S)-5-amino-2-[(2-aminoacetyl)amino]pentanoyl]amino]-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

HRID 459638
인쇄

반응식

HRID 459638 반응식
[NH2:1][C:2]1[S:6][N:5]=[C:4](/[C:7](=[N:34]/[O:35][C:36]([C:39]([O:41]C(C)(C)C)=[O:40])([CH3:38])[CH3:37])/[C:8]([NH:10][C@@H:11]2[C:32](=[O:33])[N:13]3[C:14]([C:20]([O:22]CC4C=CC(OC)=CC=4)=[O:21])=[C:15]([CH2:18]Cl)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1.C[Si](C)(C)NC(=O)C.[I-].[K+].C(OC([NH:63][CH2:64][C:65]([NH:67][C@H:68]([C:80]([NH:82][C:83]1[CH:84]=[N:85][N:86]([CH3:108])[C:87]=1[NH:88]C(C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)=[O:81])[CH2:69][CH2:70][CH2:71][NH:72]C(=O)OC(C)(C)C)=[O:66])=O)(C)(C)C>CN(C)C=O.C(OCC)(=O)C>[NH2:1][C:2]1[S:6][N:5]=[C:4](/[C:7](=[N:34]/[O:35][C:36]([C:39]([OH:41])=[O:40])([CH3:38])[CH3:37])/[C:8]([NH:10][C@@H:11]2[C:32](=[O:33])[N:13]3[C:14]([C:20]([O-:22])=[O:21])=[C:15]([CH2:18][N+:85]4[N:86]([CH3:108])[C:87]([NH2:88])=[C:83]([NH:82][C:80](=[O:81])[C@@H:68]([NH:67][C:65](=[O:66])[CH2:64][NH2:63])[CH2:69][CH2:70][CH2:71][NH2:72])[CH:84]=4)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 4875Potassium IodideHCID 25989Acetamide, N-(trimethylsilyl)-HCID 86597891tert-butyl (4S)-4-{[2-(tert-butoxycarbonylamino)acetyl]amino}-5-{[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino}-5-oxopentylcarbamateHCID 87481325Ceftolozane Impurity 20

생성물 1

HCID 141612445
(6R,7R)-3-[[5-amino-4-[[(2S)-5-amino-2-[(2-aminoacetyl)amino]pentanoyl]amino]-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
수율 4.2%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 8857Ethyl Acetate용매

실험 절차

To a solution of 4-methoxybenzyl 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)acetamido]-3-chloromethyl-3-cephem-4-carboxylate (1.0 g) in N,N-dimethylformamide (3 ml) was added N-(trimethylsilyl)acetamide (965 mg) and the mixture was stirred at room temperature for 30 minutes. To the solution was added potassium iodide (341 mg) and the mixture was stirred at room temperature for 30 minutes. To the reaction mixture was added tert-butyl (4S)-4-{[2-(tert-butoxycarbonylamino)acetyl]amino}-5-{[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino}-5-oxopentylcarbamate (1.27 g), and the whole mixture was stirred at 40° C. for 4 hours. To the reaction mixture was added ethyl acetate (100 ml) and the mixture was washed successively with brine (50 ml), 10% aqueous sodium trifluoroacetate solution (50 ml) and brine (50 ml), dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated to about 5 ml in vacuo. The concentrate was poured into diisopropyl ether (120 ml) and the resulting precipitate was collected by filtration and dried in vacuo. To a solution of the solid in methylene chloride (4.5 ml) were added anisole (1.5 ml) and trifluoroacetic acid (3.0 ml). The resulting solution was stirred at room temperature for 16 hours and poured into diisopropyl ether (120 ml). The resulting precipitate was collected by filtration and dried in vacuo to give a crude product (1.42 g), which was purified by preparative HPLC utilizing ODS column. The eluate containing a desired product was concentrated to about 20 ml in vacuo. The concentrate was further purified by preparative HPLC utilizing ODS column eluting with 8% acetonitrile/water. The eluate was concentrated to about 10 ml in vacuo. The resulting solution was lyophilized to give 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-[3-amino-4-({(2S)-5-amino-2-[(aminoacetyl)amino]pentanoyl}amino)-2-methyl-1-pyrazolio]methyl-3-cephem-4-carboxylate (46.3 mg) as an amorphous solid.

후처리

  1. stirringthe mixture was stirred at room temperature for 30 minutes
  2. stirringthe whole mixture was stirred at 40° C. for 4 hours
  3. washthe mixture was washed successively with brine (50 ml), 10% aqueous sodium trifluoroacetate solution (50 ml) and brine (50 ml)
  4. dry with materialdried over anhydrous magnesium sulfate
  5. filtrationfiltered
  6. concentrationThe filtrate was concentrated to about 5 ml in vacuo
  7. additionThe concentrate was poured into diisopropyl ether (120 ml)
  8. filtrationthe resulting precipitate was collected by filtration
  9. customdried in vacuo
  10. additionTo a solution of the solid in methylene chloride (4.5 ml) were added anisole (1.5 ml) and trifluoroacetic acid (3.0 ml)
  11. stirringThe resulting solution was stirred at room temperature for 16 hours
  12. additionpoured into diisopropyl ether (120 ml)
  13. filtrationThe resulting precipitate was collected by filtration
  14. customdried in vacuo
  15. customto give a crude product (1.42 g), which
  16. customwas purified by preparative HPLC
  17. additionThe eluate containing a desired product
  18. concentrationwas concentrated to about 20 ml in vacuo
  19. customThe concentrate was further purified by preparative HPLC
  20. washeluting with 8% acetonitrile/water
  21. concentrationThe eluate was concentrated to about 10 ml in vacuo

출처 및 근거

ORD 기록
ord-c5be349dd10148638646fc153a07421d
출처 데이터셋
uspto-grants-2007_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07192943B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트